PK/PD MODELLING OF OXYTETRACYCLINE FOR PNEUMONIA PATHOGENS
Presentation / Conference Contribution
Dorey, L., Pelligand, L., Illambas, J., Potter, T., Toutain, P. L., & Lees, P. PK/PD MODELLING OF OXYTETRACYCLINE FOR PNEUMONIA PATHOGENS
All Outputs (10)
PHARMACODYNAMIC AND PHARMACOKINETIC (PK/PD) POOLED MODELLING OF THE ANTIHYPERTENSIVE RESPONSE TO AMLODIPINE IN HYPERTENSIVE CATS
Presentation / Conference Contribution
Pelligand, L., Bijsmans, E. S., Doig, M., & Elliott, J. PHARMACODYNAMIC AND PHARMACOKINETIC (PK/PD) POOLED MODELLING OF THE ANTIHYPERTENSIVE RESPONSE TO AMLODIPINE IN HYPERTENSIVE CATS
KN MONTE CARLO SIMULATIONS AND THEIR APPLICATION IN VETERINARY MEDICINE
Presentation / Conference Contribution
Pelligand, L., & Mochel, J. KN MONTE CARLO SIMULATIONS AND THEIR APPLICATION IN VETERINARY MEDICINE
SIMULTANEOUS INTRAVENOUS AND SUBCUTANEOUS POPULATION MODELLING OF ROBENACOXIB DISPOSITION KINETICS IN CATS
Presentation / Conference Contribution
Pelligand, L., Soubret, A., King, J. N., Elliott, J., & Mochel, J. SIMULTANEOUS INTRAVENOUS AND SUBCUTANEOUS POPULATION MODELLING OF ROBENACOXIB DISPOSITION KINETICS IN CATS
GFR MEASUREMENTS IN FELINE SUBJECTS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS
Presentation / Conference Contribution
Devanur, L., Pelligand, L., Hassard, S., & Elliott, J. GFR MEASUREMENTS IN FELINE SUBJECTS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS
CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA
Presentation / Conference Contribution
Kenward, H., Pelligand, L., Tattersall, F. D., Savary-Bataille, K., & Elliott, J. CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA
THE NEXT GENERATION THERAPEUTICS FOR VETERINARY ANALGESIA
Presentation / Conference Contribution
Pelligand, L. THE NEXT GENERATION THERAPEUTICS FOR VETERINARY ANALGESIA
PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT
Presentation / Conference Contribution
Pelligand, L., King, J. N., Hormazabal, V., Toutain, P. L., Elliott, J., & Lees, P. PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT
PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
Presentation / Conference Contribution
Lees, P., Giraudel, J., Toutain, P. L., Pelligand, L., & King, J. N. PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
Presentation / Conference Contribution
Pelligand, L., King, J. N., Toutain, P. L., & Lees, P. IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION